K. Surrey

1.5k citations
9 papers · 1.2k · 1 hit paper · h-index 4

Impact in

Papers in

K. Surrey

8 papers receiving 1.1k citations

K. Surrey's Hit Papers

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE 2004 · 845 citations
8450+7+14Years since publication250500750

Peers

K. Surrey
Comparison fields: 5 of 45
  • Immunology and Allergy 384
  • Physiology 939
  • Pulmonary and Respiratory Medicine 482
  • Emergency Medical Services 49
  • Immunology 99
Replace K.M. Beeh with:
K.M. Beeh Germany
M Gilson United Kingdom
Frank Trudo United States
Juby A. Jacob‐Nara United States
Cris Roxas United Kingdom
Steen Nepper-Christensen Denmark
Anna Rigazio United Kingdom
Tracy Bridges United States
Mary Buatti Small United States
Miguel Villarreal United States
K. Surrey relative to K.M. Beeh Germany K.M. Beeh's profile →
Citations per field
00.5×1.6×
K.M. Beeh · 1×
Citations per year

Countries citing papers authored by K. Surrey

Since Specialization
Citations

This map shows the geographic impact of K. Surrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Surrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Surrey more than expected).

Fields of papers citing papers by K. Surrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Surrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Surrey. The network helps show where K. Surrey may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Surrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Surrey Line = papers co-authored together K. Surrey links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
Hit paper breakdown →
2004845
2 2004310
3 20034
4 20043
5 20062
6 20052
7 20042
8 20061
9 20021

About K. Surrey

K. Surrey is a scholar working on Physiology, Immunology and Allergy, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Infectious Diseases, having authored 9 papers that have together received 1.2k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (6 papers), Allergic Rhinitis and Sensitization (4 papers), Inhalation and Respiratory Drug Delivery (2 papers), Food Allergy and Anaphylaxis Research (1 paper), Pharmaceutical studies and practices (1 paper) and Respiratory and Cough-Related Research (1 paper). The work is most often cited by research in Immunology and Allergy (384 citations), Physiology (939 citations), Pulmonary and Respiratory Medicine (482 citations), Emergency Medical Services (49 citations) and Immunology (99 citations). K. Surrey has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include S. Hedgecock, Martin Blogg, Marc Humbert, Jean Bousquet, Giorgio Walter Canonica, H. Fox, Raymond G. Slavin, Sância Ramos, Jon G. Ayres and Richard Beasley. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Allergy and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact